Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall of Fenofibrate (Fenoglide) Physician Samples
The generic manufacturer Sciele Pharma, Inc has voluntarily recalled one lot number of a physician sample of Fenoglide (Fenofibrate) 120 mg tablets in 7 Count Bottles. This recall notice only applies to Lot Number 0704784 of a physician sample of fenofibrate called "Fenoglide" 120 mg tablets. These tablets are being recalled because they failed to dissolve. Fenoglide (fenofibrate) is used to lower cholesterol. For more information and a complete list of lot numbers being recalled, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/2008/ucm120531.htm
Learn More

Recall of One Lot of Fenoglide Samples
Sciele Pharma, Inc has voluntarily recalled one lot number of a physician sample of Fenoglide (Fenofibrate) 120 mg tablets in 7 Count Bottles. Fenoglide (fenofibrate) is used to lower cholesterol. This recall notice only applies to Lot Number 0802584 of a physician sample of fenofibrate called "Fenoglide" 120 mg tablets. These tablets are being recalled because they failed to dissolve when tested by the manufacturer. For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm179528.htm
Learn More

Date Published Title Drug Source
2008-11-25 Recall of Fenofibrate (Fenoglide) Physician Samples Fenofibrate FDA
2009-08-21 Recall of One Lot of Fenoglide Samples Fenofibrate FDA
2010-03-15 FDA Makes Statement on the ACCORD Lipid Trial Fenofibrate FDA
2010-03-15 FDA Makes Statement on the ACCORD Lipid Trial Fenofibric Acid FDA
2011-11-09 FDA: Trilipix (fenofibric acid) May Not Lower a Patient's Risk of Having a Heart Attack or Stroke Fenofibric Acid FDA
2007-09-13 Fentora (fentanyl buccal tablet) and the occurrence of serious adverse events Fentanyl FDA
2007-09-26 Public Health Advisory for Fentora (fentanyl buccal) Fentanyl FDA
2007-12-21 Drug information update on Fentanyl Transdermal System (marketed as Duragesic) Fentanyl FDA
2008-02-13 Recall of fentanyl patches Fentanyl Manufacturer
2008-08-11 Recall - single lot of Watson brand 75 mcg/hr Fentanyl Transdermal System patches Fentanyl Manufacturer
2008-12-31 Recall of Two Lots of FENTANYL (also sold as DURAGESIC) 50 mcg/hr Transdermal System Patches Fentanyl Manufacturer
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Fentanyl FDA
2009-08-10 Recall of Single Lot of Watson Brand FENTANYL 100 mcg/hr Transdermal System Patches Fentanyl FDA
2010-10-22 Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/hr Fentanyl Manufacturer
2010-11-04 Actavis Issues Consumer Update to Recall of Fentanyl Transdermal System 25 mcg/h Patches Fentanyl Manufacturer
2012-01-02 FDA Approves Risk Management Plan for Entire Class of Transmucosal Immediate-Release Fentanyl (TIRF) Medicines Fentanyl FDA
2012-04-19 Important Information for the Safe Use of Fentanyl Patches Fentanyl FDA
2012-07-20 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Recalls Single Lot of Duragesic 25 mcg/h Fentanyl FDA
2013-09-25 Changes to Duragesic (Fentanyl) Packaging to Reduce Risk of Accidental Exposure Fentanyl FDA
2009-02-04 Recall on ETHEX Brand Iron Supplements Manufacturer
Back to Consumer Med Safety